Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with or without azasetron for prevention of postoperative nausea and vomiting in women undergoing posterior lumbar fusion
ChiCTR2100049246Phase 4Not yet recruiting
- Sponsor
- Southern District of Anhui Provincial Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and azasetron in postoperative nausea and vomiting (PONV) and postoperative pain (3 arms), sponsored by Southern District of Anhui Provincial Hospital. Primary endpoints: Postoperative nausea and vomiting and Use of remedial antiemetic medication. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
dexmedetomidineazasetron
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2100049246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049246.